Nanomedicines for endothelial disorders
Author(s)
Toth, Michael J.; Sei, Yoshitaka J.; Mulder, Willem J.M.; Fayad, Zahi A.; Farokhzad, Omid C.; Kim, YongTae; Lee Chung, Bomy; Kamaly, Nazila; Langer, Robert S; Becraft, Jacob Robert; ... Show more Show less
DownloadLanger_Nanomedicines for Endothelial Disorders.pdf (2.303Mb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
The endothelium lines the internal surfaces of blood and lymphatic vessels and has a critical role in maintaining homeostasis. Endothelial dysfunction is involved in the pathology of many diseases and conditions, including disorders such as diabetes, cardiovascular diseases, and cancer. Given this common etiology in a range of diseases, medicines targeting an impaired endothelium can strengthen the arsenal of therapeutics. Nanomedicine - the application of nanotechnology to healthcare - presents novel opportunities and potential for the treatment of diseases associated with an impaired endothelium. This review discusses therapies currently available for the treatment of these disorders and highlights the application of nanomedicine for the therapy of these major disease complications. Keywords: Endothelium; Nanomedicine; Endothelial disorder; Diabetes; Atherosclerosis; Cancer
Date issued
2016-01Department
Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Chemical Engineering; Koch Institute for Integrative Cancer Research at MITJournal
Nano Today
Publisher
Elsevier
Citation
Lee Chung, et al. “Nanomedicines for Endothelial Disorders.” Nano Today 10, 6 (December 2015): 759–776 © 2015 Elsevier Ltd
Version: Author's final manuscript
ISSN
1748-0132